Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04094818 · ClinicalTrials.gov registry record
TriVerity in the Diagnosis and Prognosis of Emergency Department Patients With Suspected Infections and Suspected Sepsis
A clinical trial, sponsored by Inflammatix.
- Completed
- Registry status
- 1,441
- Enrollment target
NCT04094818 is a clinical trial that has completed, run by Inflammatix. The registered enrollment target is 1,441 participants.
The verdict
NCT04094818 has completed, sponsored by Inflammatix.
- COMPLETED
- Registry status
- 1,441 participants
- Enrollment target
Study Summary
This study will analyze gene expression and other laboratory data from biological samples collected from participants with suspected respiratory, urinary, intra-abdominal, and/or skin \& soft tissue infections; or suspected sepsis of any cause.
Interventions
- DIAGNOSTIC_TEST TriVerity
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,441 participants |
| Start Date | 2020-02-28 |
| Est. Completion | 2024-09-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04094818
The ClinicalTrials.gov registry entry for NCT04094818 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,441 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Inflammatix, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which TriVerity is the first listed.
NCT04094818 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04094818 about?
NCT04094818 is a clinical study titled "TriVerity in the Diagnosis and Prognosis of Emergency Department Patients With Suspected Infections and Suspected Sepsis". This study will analyze gene expression and other laboratory data from biological samples collected from participants with suspected respiratory, urinary, intra-abdominal, and/or skin \& soft tissue infections; or suspected sepsis of any cause.
What is the current status of trial NCT04094818?
This trial is currently completed. The enrollment target is 1,441 participants. The study started on 2020-02-28. Estimated completion is 2024-09-30.
What interventions are being tested in trial NCT04094818?
The interventions under investigation include: TriVerity (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04094818?
This trial is sponsored by Inflammatix, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.